Nitto Avecia Company Updates | Glassdoor

Company Updates

  • http://glassdoor.com/slink.htm?key=vQex6

    Nitto Denko Avecia to debut its expanded API plant next month

    Nitto Denko Avecia, a CMO, said it will open its expanded oligonucleotide API manufacturing facility next month in Milford, Massachusetts. The maker of oligonucleotides, which are DNA or RNA molecules used in a variety of applications in genetic testing, research, and forensics, said it expanded the plant by 20,000 square feet for manufacturing and office space.

  • http://glassdoor.com/slink.htm?key=vQeg8

    Milford drug manufacturing facility expanding

    Avecia, a pharmaceutical manufacturer in Milford, says it is building what will become the largest manufacturing site in the world for a specialized drug ingredient called oligonucleotide. The expansion, which will add 20,000 square feet of space, will more than double the Milford site's total capacity, the company said in an announcement Thursday.

  • Nitto Denko Avecia Announces Opening of Manufacturing Expansion

    July 13, 2017 /PRNewswire/ -- Nitto Denko Avecia Inc. (Avecia) announced today the opening of its new oligonucleotide API (active pharmaceutical ingredients) manufacturing facility in The opening will commence with a ribbon cutting ceremony in August 2017 onsite at the facility.

Work at Nitto Avecia? Share Your Experiences

Nitto Avecia
  • Star
  • Star
  • Star
  • Star
  • Star
 
Click to Rate
or